← Google Interview Insights

Google·Data Scientist·Technical Phone Screen·Senior

Senior
Jun 2026

Summary

A deep-dive causal inference question at Google for a DS role, framed around a music app feature and speeding. The whole thing was one long multi-part problem that kept escalating in complexity.

Questions Asked (5)

Q1

A lawyer is concerned that users who listen to a 'Commute' playlist in a mobile app drive faster. How would you define the population, unit of analysis, treatment, and outcome for a study on this, including precise time windows?

A/B Testing & ExperimentationProduct Analytics & Metrics
Author's notes

This part felt deceptively clean but I kept second-guessing myself on the unit of analysis.

Create a free account to read the full note

AI HintsAI Generated

Suggested Approach

Start by clarifying the causal question: does listening to the 'Commute' playlist cause faster driving? Then define each component (population, unit, treatment, outcome) with precise operational definitions and time windows that align with the causal mechanism. Emphasize that the unit of analysis should be the trip (or driver-trip) to avoid aggregation bias, and specify time windows for treatment exposure and outcome measurement that capture immediate effects.

Pro tip: Mention that you would pre-register the analysis plan and consider using a within-driver design (e.g., switchback or randomized encouragement) to control for driver-level confounders, since randomizing playlist exposure per trip may be unethical or impractical.

1. Clarify the causal question and scope

Restate the hypothesis as a causal effect: does listening to the 'Commute' playlist during a trip cause an increase in driving speed? Define the target estimand (e.g., average treatment effect on the treated) and acknowledge potential confounders like time of day, route, and driver characteristics.

2. Define population and unit of analysis

Population: all drivers who use the mobile app and have access to the 'Commute' playlist. Unit of analysis: the individual trip (or driver-trip), because treatment and outcome vary per trip. If interested in driver-level effects, use driver as unit but then treatment is a summary (e.g., proportion of trips with playlist).

3. Specify treatment and control conditions

Treatment: listening to the 'Commute' playlist during a trip. Control: not listening to the playlist (or listening to a neutral playlist). Define exposure precisely: e.g., playlist played for at least 50% of the trip duration, or any listening. Consider dosage (minutes listened) and timing (start, middle, end).

4. Define outcome and measurement

Outcome: driving speed, measured as average speed (mph) or proportion of time exceeding speed limit. Use GPS data from the app. Specify aggregation: per trip. Consider secondary outcomes like max speed, speed variance, or harsh braking events.

5. Set precise time windows

Treatment window: from trip start to trip end (or first 10 minutes if interested in immediate effect). Outcome window: same as treatment window for contemporaneous effect; for lagged effects, measure speed in the 5 minutes after playlist ends. Ensure windows align to avoid reverse causality.

Key Points to Mention

  • Unit of analysis should be the trip, not the driver, to capture within-driver variation and avoid ecological fallacy.
  • Treatment must be clearly defined: binary (listened vs not) or continuous (minutes listened), with a minimum exposure threshold.
  • Outcome should be objective and measured via app sensors (e.g., GPS speed), not self-reported.
  • Time windows must be precise: treatment during trip, outcome during same trip, with possible lagged effects.
  • Confounders: time of day, route type, traffic, driver demographics, and music tempo/volume.
  • Ethical and practical considerations: randomizing playlist exposure may be unethical; consider observational study with propensity score matching or instrumental variables.

AI-generated suggestions, not part of the candidate's original notes. May be inaccurate — verify before relying on them.

Q2

What are at least five major confounders in this study, and how would you measure each one?

A/B Testing & ExperimentationData Modeling
Author's notes

Got five without too much trouble: time of day, road type, driver age, trip length, and weather.

Create a free account to read the full note

AI HintsAI Generated

Suggested Approach

Start by clarifying the study design and context, then systematically identify potential confounders by considering common sources like selection bias, measurement error, and external factors. For each confounder, propose a specific measurement method and explain how it would be incorporated into the analysis to adjust for its effect.

Pro tip: Demonstrate awareness that confounders can be addressed through design (e.g., randomization, blocking) or analysis (e.g., regression adjustment, stratification), and mention that in A/B testing, pre-experiment covariates and invariant metrics help detect and mitigate confounding.

1. Clarify the study context

Ask clarifying questions about the study design, population, treatment, and outcome to understand the potential for confounding. This ensures your answer is tailored to the specific scenario.

2. Identify potential confounders

Brainstorm at least five major confounders by considering common categories: selection bias, temporal trends, user characteristics, external events, and measurement issues.

3. Propose measurement methods

For each confounder, specify how it would be measured (e.g., using pre-experiment data, surveys, logs, or external data sources) and at what granularity.

4. Explain adjustment techniques

Describe how you would adjust for each confounder in the analysis, such as stratification, regression, propensity score matching, or sensitivity analysis.

5. Validate and monitor

Discuss how you would validate the adjustments (e.g., checking covariate balance, placebo tests) and monitor for residual confounding during the experiment.

Key Points to Mention

  • Selection bias: measure via pre-experiment covariates and check randomization balance.
  • Temporal confounders: use time-series analysis or include time fixed effects.
  • User-level confounders: collect demographics, behavior, and device data; use regression adjustment.
  • External events: track external factors (e.g., holidays, news) and include as covariates or use difference-in-differences.
  • Measurement error: validate instruments, use multiple data sources, and conduct sensitivity analyses.
  • Novelty and primacy effects: measure via exposure time and user learning curves, and analyze by cohort.

AI-generated suggestions, not part of the candidate's original notes. May be inaccurate — verify before relying on them.

Q3

Design a safe randomized controlled trial to test whether the playlist causes faster driving. Cover eligibility criteria, safety guardrails, kill switches, metrics, and stopping rules.

A/B Testing & ExperimentationProduct Sense & Ideation
Author's notes

This is where the 'lawyer is worried' framing really kicked in and I actually liked it as a constraint.

Create a free account to read the full note

AI HintsAI Generated

Suggested Approach

Start by framing the experiment as a safety-critical A/B test where the primary goal is to protect participants while measuring the causal effect of music on driving speed. Propose a randomized design with strict eligibility, real-time monitoring, and pre-registered stopping rules to ensure ethical and statistical validity.

Pro tip: Emphasize that safety guardrails and kill switches must be automated and independent of the experiment team to avoid bias, and that the primary metric should be a safety proxy (e.g., speed variance) rather than just average speed.

1. Define eligibility and randomization

Specify inclusion/exclusion criteria (e.g., age, driving history, vehicle type) and randomize participants to treatment (playlist) or control (no music/podcast) using blocked randomization to balance covariates.

2. Design safety guardrails and kill switches

Implement real-time monitoring of speed and driving behavior with automatic alerts and a kill switch that stops the experiment if safety thresholds are breached (e.g., speed > 20% above limit).

3. Select metrics and measurement

Choose primary metric (e.g., mean speed or proportion of time speeding) and secondary metrics (e.g., speed variance, hard braking events). Use in-vehicle sensors or smartphone telematics for objective data.

4. Pre-register stopping rules and analysis plan

Define stopping rules (e.g., O'Brien-Fleming alpha spending) for safety and efficacy, and specify the statistical test (e.g., ANCOVA) and power analysis to detect a clinically meaningful difference.

5. Address ethical and operational considerations

Obtain IRB approval, ensure informed consent, and plan for data privacy. Consider a run-in period and debrief participants, offering them the option to withdraw data.

Key Points to Mention

  • Informed consent and IRB approval for human subjects research
  • Use of objective driving data (e.g., OBD-II, GPS) to avoid self-report bias
  • Pre-registration of analysis plan to prevent p-hacking
  • Interim analyses with alpha spending to monitor safety and efficacy
  • Blinding of participants and analysts where possible
  • Consideration of confounders like time of day, traffic, and road type

AI-generated suggestions, not part of the candidate's original notes. May be inaccurate — verify before relying on them.

Q4

If a proper experiment isn't feasible, what quasi-experimental approaches would you use? Walk through within-driver fixed effects, staggered adoption difference-in-differences, instrumental variables using exogenous surfacing changes, and regression discontinuity on a ranking score threshold. Include identifying assumptions and falsification tests for each.

A/B Testing & ExperimentationTechnical Trade-offs
Author's notes

This was the hardest part and honestly I think I only did two of the four strategies justice.

Create a free account to read the full note

AI HintsAI Generated

Suggested Approach

Start by framing the problem: when randomization is infeasible, quasi-experimental methods can still provide credible causal estimates if their identifying assumptions hold. Then systematically walk through each method (within-driver FE, staggered DiD, IV, RD), explicitly stating the key assumption and at least one falsification test for each, and tie them to practical Google contexts like driver behavior or ranking thresholds.

Pro tip: Emphasize that no quasi-experimental method is a silver bullet—each requires strong assumptions and robustness checks. Show maturity by discussing how you'd triangulate multiple methods and quantify sensitivity to assumption violations, rather than claiming one method is definitive.

1. Frame the causal inference challenge

Acknowledge that when A/B tests aren't possible, we need quasi-experimental designs that mimic randomization. State that each method relies on untestable assumptions, so we must combine design with falsification tests.

2. Within-driver fixed effects

Explain that this controls for time-invariant driver characteristics by comparing a driver to themselves over time. Key assumption: no time-varying confounders correlated with treatment. Falsification: test for pre-trends or placebo outcomes.

3. Staggered adoption difference-in-differences

Describe using variation in treatment timing across units. Key assumption: parallel trends in absence of treatment. Falsification: event-study plots to check pre-trends, and Goodman-Bacon decomposition to assess bias from staggered timing.

4. Instrumental variables with exogenous surfacing changes

Use an instrument that affects treatment but not the outcome except through treatment. Key assumptions: relevance (first stage) and exclusion restriction. Falsification: test for weak instruments (F-stat > 10), overidentification tests if multiple instruments, and placebo outcomes.

5. Regression discontinuity on a ranking score threshold

Exploit a cutoff in a ranking score that determines treatment. Key assumption: continuity of potential outcomes at the threshold. Falsification: McCrary density test for manipulation, covariate balance tests, and placebo cutoffs.

Key Points to Mention

  • Within-driver fixed effects: controls for time-invariant heterogeneity, but requires no time-varying confounders; falsify with pre-trend tests.
  • Staggered DiD: parallel trends assumption; use event-study plots and Goodman-Bacon decomposition to check for pre-trends and bias.
  • Instrumental variables: relevance and exclusion restriction; test with first-stage F-stat, overidentification tests, and placebo outcomes.
  • Regression discontinuity: continuity assumption; falsify with McCrary test, covariate balance, and placebo cutoffs.
  • Triangulation: use multiple methods and sensitivity analysis to strengthen causal claims.
  • Practical examples: driver behavior (within-driver), feature rollouts (staggered DiD), surfacing changes (IV), ranking thresholds (RD).

AI-generated suggestions, not part of the candidate's original notes. May be inaccurate — verify before relying on them.

Q5

How do you handle the fact that treatment can start mid-trip, that compliance is partial, and that some users in the data aren't drivers at all? What data granularity do you need to avoid leakage?

A/B Testing & ExperimentationData Modeling
Author's notes

Mid-trip treatment was actually my best moment.

Create a free account to read the full note

AI HintsAI Generated

Suggested Approach

Acknowledge the complexities of mid-trip treatment start, partial compliance, and non-driver users, then propose a granular data model with trip-level and user-level flags to define treatment windows and filter populations. Emphasize the need for careful leakage prevention by aligning analysis units with the randomization unit and using time-aware features.

Pro tip: Frame the problem as an intent-to-treat (ITT) analysis with per-protocol (PP) as a secondary view, and explicitly discuss how you'd instrument the experiment to capture mid-trip starts and non-driver exposure.

1. Clarify the experiment design and randomization unit

Determine whether randomization occurs at the user, trip, or driver level, as this dictates the appropriate analysis unit and how to handle non-drivers and partial compliance.

2. Define treatment exposure windows

For each user or trip, compute the exact time treatment began (e.g., mid-trip) and create a binary or time-varying treatment indicator that respects the start time to avoid contaminating pre-treatment periods.

3. Filter and segment the analysis population

Exclude or separately analyze users who are not drivers (e.g., riders) and account for partial compliance by using ITT and PP analyses, possibly with compliance-adjusted estimators.

4. Choose granularity to prevent leakage

Use trip-level or even event-level data with timestamps to ensure that features and outcomes are measured only after treatment start and that no future information leaks into the analysis.

5. Validate with sensitivity checks

Run robustness checks such as varying the exposure window, excluding edge cases, and comparing ITT vs. PP results to ensure conclusions are not driven by data artifacts.

Key Points to Mention

  • Intent-to-treat (ITT) vs. per-protocol (PP) analysis to handle partial compliance
  • Time-varying treatment indicators to account for mid-trip starts
  • User-level vs. trip-level randomization and analysis units
  • Exclusion or separate modeling of non-driver users (e.g., riders)
  • Leakage prevention via timestamp alignment and avoiding future data
  • Sensitivity analysis to test robustness of results

AI-generated suggestions, not part of the candidate's original notes. May be inaccurate — verify before relying on them.